Humoral SARS-CoV-2 vaccine responses are durable in solid organ transplant recipients with and without HIV
medRxiv [Preprint]. 2025 May 8:2025.05.07.25327192. doi: 10.1101/2025.05.07.25327192.
PMID:
Nosocomial lower respiratory tract infections in patients with immunosuppression: a cohort study
Ann Intensive Care. 2025 May 6;15(1):61. doi: 10.1186/s13613-025-01462-y.
PMID:
Underlying health biases in previously-infected SARS-CoV-2 vaccination recipients: A cohort study
J Infect. 2025 Jun;90(6):106497. doi: 10.1016/j.jinf.2025.106497. Epub 2025 Apr 30.
PMID:
Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1
Npj Viruses. 2024 Aug 6;2(1):28. doi: 10.1038/s44298-024-00038-0.
PMID:
Prevalence of Chronic Pulmonary Aspergillosis in Patients With Mycobacterial and Non-Mycobacterial Tuberculosis Infection of the Lung: A Systematic Review and Meta-Analysis
Mycoses. 2025 Apr;68(4):e70060. doi: 10.1111/myc.70060.
PMID:
Diabetes, glycaemic traits and cardiovascular disease in females and males: Observational and Mendelian randomisation analyses in the UK Biobank
Diabetes Obes Metab. 2025 Jul;27(7):3789-3799. doi: 10.1111/dom.16406. Epub 2025 Apr 21.
PMID:
Eosinophil innate immune memory after bacterial skin infection promotes allergic lung inflammation
Sci Immunol. 2025 Apr 4;10(106):eadp6231. doi: 10.1126/sciimmunol.adp6231. Epub 2025 Apr 4.
PMID:
Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody
J Exp Med. 2025 Jun 2;222(6):e20241930. doi: 10.1084/jem.20241930. Epub 2025 Apr 3.
PMID:
Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models
Front Immunol. 2025 Mar 17;16:1524477. doi: 10.3389/fimmu.2025.1524477. eCollection 2025.
PMID:
Convergent and clonotype-enriched mutations in the light chain drive affinity maturation of a public antibody
bioRxiv [Preprint]. 2025 Mar 10:2025.03.07.642041. doi: 10.1101/2025.03.07.642041.
PMID: